aluates Reports

$ 0.0

Automative

Global Long Acting Insulins Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-34I906

Global Long Acting Insulins Market Insights Forecast to 2028

BUY CHAPTERS

Global Long Acting Insulins Market Research Report 2024

Code: QYRE-Auto-34I906

Report

April 2024

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Wockhardt UK

Novo Nordisk

Long Acting Insulins Market

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.

The global Long Acting Insulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Long Acting Insulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Long Acting Insulins in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Long Acting Insulins include Novo Nordisk, Sanofi and Wockhardt UK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Long Acting Insulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Insulins.

Report Scope

The Long Acting Insulins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Acting Insulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long Acting Insulins companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long Acting Insulins Market Report

Report Metric	Details
Report Name	Long Acting Insulins Market
Segment by Type	Insulin Glargine Insulin Determir Insulin Degludec Long Acting Animal Insulin
Segment by Application	Home Use Medical Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Sanofi, Wockhardt UK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Insulins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Long Acting Insulins Market report?

Ans: The main players in the Long Acting Insulins Market are Novo Nordisk, Sanofi, Wockhardt UK

What are the Application segmentation covered in the Long Acting Insulins Market report?

Ans: The Applications covered in the Long Acting Insulins Market report are Home Use, Medical Institutions, Others

What are the Type segmentation covered in the Long Acting Insulins Market report?

Ans: The Types covered in the Long Acting Insulins Market report are Insulin Glargine, Insulin Determir, Insulin Degludec, Long Acting Animal Insulin

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Insulin Glargine

1.2.3 Insulin Determir

1.2.4 Insulin Degludec

1.2.5 Long Acting Animal Insulin

1.3 Market by Application

1.3.1 Global Long Acting Insulins Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Home Use

1.3.3 Medical Institutions

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long Acting Insulins Market Perspective (2019-2030)

2.2 Long Acting Insulins Growth Trends by Region

2.2.1 Global Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Long Acting Insulins Historic Market Size by Region (2019-2024)

2.2.3 Long Acting Insulins Forecasted Market Size by Region (2025-2030)

2.3 Long Acting Insulins Market Dynamics

2.3.1 Long Acting Insulins Industry Trends

2.3.2 Long Acting Insulins Market Drivers

2.3.3 Long Acting Insulins Market Challenges

2.3.4 Long Acting Insulins Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long Acting Insulins Players by Revenue

3.1.1 Global Top Long Acting Insulins Players by Revenue (2019-2024)

3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2019-2024)

3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Long Acting Insulins Revenue

3.4 Global Long Acting Insulins Market Concentration Ratio

3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2023

3.5 Long Acting Insulins Key Players Head office and Area Served

3.6 Key Players Long Acting Insulins Product Solution and Service

3.7 Date of Enter into Long Acting Insulins Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Long Acting Insulins Breakdown Data by Type

4.1 Global Long Acting Insulins Historic Market Size by Type (2019-2024)

4.2 Global Long Acting Insulins Forecasted Market Size by Type (2025-2030)

5 Long Acting Insulins Breakdown Data by Application

5.1 Global Long Acting Insulins Historic Market Size by Application (2019-2024)

5.2 Global Long Acting Insulins Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Long Acting Insulins Market Size (2019-2030)

6.2 North America Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Long Acting Insulins Market Size by Country (2019-2024)

6.4 North America Long Acting Insulins Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long Acting Insulins Market Size (2019-2030)

7.2 Europe Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Long Acting Insulins Market Size by Country (2019-2024)

7.4 Europe Long Acting Insulins Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long Acting Insulins Market Size (2019-2030)

8.2 Asia-Pacific Long Acting Insulins Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Long Acting Insulins Market Size by Region (2019-2024)

8.4 Asia-Pacific Long Acting Insulins Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Long Acting Insulins Market Size (2019-2030)

9.2 Latin America Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Long Acting Insulins Market Size by Country (2019-2024)

9.4 Latin America Long Acting Insulins Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long Acting Insulins Market Size (2019-2030)

10.2 Middle East & Africa Long Acting Insulins Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Long Acting Insulins Market Size by Country (2019-2024)

10.4 Middle East & Africa Long Acting Insulins Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Detail

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Long Acting Insulins Introduction

11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024)

11.1.5 Novo Nordisk Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Long Acting Insulins Introduction

11.2.4 Sanofi Revenue in Long Acting Insulins Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Wockhardt UK

11.3.1 Wockhardt UK Company Detail

11.3.2 Wockhardt UK Business Overview

11.3.3 Wockhardt UK Long Acting Insulins Introduction

11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024)

11.3.5 Wockhardt UK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sanofi

Wockhardt UK

Novo Nordisk

List of Tables

Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Insulin Glargine

Table 3. Key Players of Insulin Determir

Table 4. Key Players of Insulin Degludec

Table 5. Key Players of Long Acting Animal Insulin

Table 6. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Long Acting Insulins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Long Acting Insulins Market Share by Region (2019-2024)

Table 10. Global Long Acting Insulins Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Long Acting Insulins Market Share by Region (2025-2030)

Table 12. Long Acting Insulins Market Trends

Table 13. Long Acting Insulins Market Drivers

Table 14. Long Acting Insulins Market Challenges

Table 15. Long Acting Insulins Market Restraints

Table 16. Global Long Acting Insulins Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Long Acting Insulins Market Share by Players (2019-2024)

Table 18. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)

Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Long Acting Insulins Product Solution and Service

Table 23. Date of Enter into Long Acting Insulins Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Long Acting Insulins Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Long Acting Insulins Revenue Market Share by Type (2019-2024)

Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Long Acting Insulins Revenue Market Share by Type (2025-2030)

Table 29. Global Long Acting Insulins Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Long Acting Insulins Revenue Market Share by Application (2019-2024)

Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Long Acting Insulins Revenue Market Share by Application (2025-2030)

Table 33. North America Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Long Acting Insulins Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Long Acting Insulins Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Long Acting Insulins Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Long Acting Insulins Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Long Acting Insulins Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Long Acting Insulins Market Size by Country (2025-2030) & (US$ Million)

Table 48. Novo Nordisk Company Detail

Table 49. Novo Nordisk Business Overview

Table 50. Novo Nordisk Long Acting Insulins Product

Table 51. Novo Nordisk Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 52. Novo Nordisk Recent Development

Table 53. Sanofi Company Detail

Table 54. Sanofi Business Overview

Table 55. Sanofi Long Acting Insulins Product

Table 56. Sanofi Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 57. Sanofi Recent Development

Table 58. Wockhardt UK Company Detail

Table 59. Wockhardt UK Business Overview

Table 60. Wockhardt UK Long Acting Insulins Product

Table 61. Wockhardt UK Revenue in Long Acting Insulins Business (2019-2024) & (US$ Million)

Table 62. Wockhardt UK Recent Development

Table 63. Research Programs/Design for This Report

Table 64. Key Data Information from Secondary Sources

Table 65. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Long Acting Insulins Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Long Acting Insulins Market Share by Type: 2023 VS 2030

Figure 3. Insulin Glargine Features

Figure 4. Insulin Determir Features

Figure 5. Insulin Degludec Features

Figure 6. Long Acting Animal Insulin Features

Figure 7. Global Long Acting Insulins Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Long Acting Insulins Market Share by Application: 2023 VS 2030

Figure 9. Home Use Case Studies

Figure 10. Medical Institutions Case Studies

Figure 11. Others Case Studies

Figure 12. Long Acting Insulins Report Years Considered

Figure 13. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Long Acting Insulins Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Long Acting Insulins Market Share by Region: 2023 VS 2030

Figure 16. Global Long Acting Insulins Market Share by Players in 2023

Figure 17. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2023

Figure 19. North America Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Long Acting Insulins Market Share by Country (2019-2030)

Figure 21. United States Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Long Acting Insulins Market Share by Country (2019-2030)

Figure 25. Germany Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Long Acting Insulins Market Share by Region (2019-2030)

Figure 33. China Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Long Acting Insulins Market Share by Country (2019-2030)

Figure 41. Mexico Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Long Acting Insulins Market Share by Country (2019-2030)

Figure 45. Turkey Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 48. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 49. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2019-2024)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions